Avav Stock faces split outlook ahead of March earnings

Recent coverage shows avav stock sitting at the center of sharply divergent views as March earnings approach. Seventeen analysts collectively imply roughly 42% upside, even as at least one prominent analyst house maintains an "Underperform" stance; the divergence matters because investors will watch margins, backlog conversion and the upcoming March report for signs of recovery or continued weakness.

Avav Stock: Analysts and ratings

Analyst sentiment is polarized. One set of analyst tallies lists 17 Strong Buy/Buy-scale endorsements that, on average, imply about 42% upside from then-current levels and an average target near the mid-three hundreds. At the same time, an independent research firm reiterated an "Underperform" rating. Aggregate tallies in coverage show one Strong Buy, eighteen Buy, two Hold and two Sell, producing an average consensus labeled a "Moderate Buy. " This split leaves valuation views and near-term catalysts in focus as the company heads into the March earnings window.

Profitability and margin pressures

Coverage highlights a notable deterioration in margins and per-share profitability. Gross margin was reported to have fallen to 22% from 39%, a drop attributed in the coverage to a services-heavy revenue mix and intangible amortization. Over a five-year span, operating margin declined by 8. 4 percentage points and was a negative 6. 5% on a trailing 12-month basis. Free cash flow margin for the trailing 12 months was described as negative 17. 6%, with an overall five-year margin decline of about 19 percentage points. Earnings-per-share trends also raised flags: EPS declined roughly 9. 9% annually over the last two years while revenue expanded by 44. 8% in that timeframe, indicating margin compression even amid top-line growth.

Valuation, trading and outlook

Valuation metrics vary across the coverage. Forward price-to-earnings multiples cited include figures near 57. 6x and roughly 83x; another dataset listed a current P/E that was negative on a trailing basis. Shares were described as trading down to $222. 35 in midday trading (ET) in one account, while separate commentary noted a six-month rise to $261. 95, illustrating short-term volatility. Market data in recent coverage listed a market capitalization near $11. 10 billion, a 52-week range from about $102. 25 to $417. 86, a 50-day moving average near $287. 75 and a 200-day moving average near $294. 15. Liquidity and balance-sheet indicators cited included a quick ratio of 4. 29, a current ratio of 5. 08 and a debt-to-equity ratio of 0. 16.

• Key takeaways: backlog and contracts give revenue visibility, but margin collapse and recent EPS misses raise near-term risk ahead of March earnings.

What to watch next: March earnings are the immediate catalyst. Observable indicators to monitor in that report include gross- and operating-margin trends, whether services revenue mix effects ease, any update on backlog conversion, and whether EPS beats or misses expectations after two consecutive quarterly shortfalls. If margins show tangible recovery, the more optimistic analyst targets could gain traction; if margin weakness persists, the premium valuation noted in coverage may leave limited downside protection.